Company BRAIN Biotech AG

Equities

BNN

DE0005203947

Environmental Services & Equipment

Market Closed - Xetra Other stock markets 12:35:15 2026-03-13 pm EDT			5-day change	1st Jan Change
2.700 ^EUR	+0.37%		+15.38%	+7.14%

Feb. 24	BRAIN Biotech AG Reports Earnings Results for the First Quarter Ended December 31, 2025	CI
Jan. 20	BRAIN Biotech AG, 2025 Earnings Call, Jan 14, 2026

Business description: BRAIN Biotech AG

BRAIN Biotech AG, is formerly known as B.R.A.I.N. Biotechnology Research and Information Network AG, is a Germany -based Company. The Company is a supplier of bio-based products and solutions such as enzymes and proteins, microbial production strains, natural substances, and biotechnological solutions for industrial processes in the areas of nutrition, health, and the environment. BRAIN Biotech is also offers contract research and development in the fields of enzyme technology, microbial strain development and bioprocess development.

Number of employees: 292

Sales by Activity: BRAIN Biotech AG

Fiscal Period: September	2021 (EUR)	2022 (EUR)	2023 (EUR)	2024 (EUR)	2025 (EUR)
Brainbiocatalysts	-	-	-	-	45.8M
BRAINBioincubator	-	-	944K	2.05M	4.41M
Bioproducts	28.3M	37.7M	42.64M	42.64M	-
Consolidation	-159K	-118K	-39K	-286K	-
Bioscience (excl. Bioincubator)	-	-	12.68M	11.1M	-
Bio Science	11.08M	12.71M	-	-	-

See all business segments

Geographical breakdown of sales: BRAIN Biotech AG

Fiscal Period: September	2021 (EUR)	2022 (EUR)	2023 (EUR)	2024 (EUR)	2025 (EUR)
Other Abroad	10.7M	13.58M	16.47M	16.58M	16.48M
USA	8.86M	14.02M	15.31M	13.51M	12.3M
Netherlands	4.98M	6.54M	10.38M	11.28M	8.85M
Germany	7.07M	7.93M	5.66M	6.65M	5.52M
United Kingdom	3.7M	3.64M	4.77M	3.68M	4.3M
France	3.08M	3.8M	2.74M	2.92M	2.18M

See all geographic segments

Executive Committee: BRAIN Biotech AG

Manager	Title	Age	Since
Adriaan Moelker CEO	Chief Executive Officer	62	2020-01-31
Michael Schneiders DFI	Director of Finance/CFO	56	2022-09-30
Alexander Pelzer CTO	Chief Tech/Sci/R&D Officer	40	2022-12-31
Martina Schuster IRC	Investor Relations Contact	-	-
Robert Hoekstra PRN	Corporate Officer/Principal	-	2022-03-31

See BRAIN BIOTECH AG governance

Composition of the Board of Directors: BRAIN Biotech AG

Director	Title	Age	Since
Anna Carina Eichhorn BRD	Director/Board Member	54	2017-03-08
Michael Majerus CHM	Chairman	65	2023-03-07
Stephen Catling BRD	Director/Board Member	61	2020-10-13
Christine Uekert BRD	Director/Board Member	62	2023-03-07
Florian Schnabel BRD	Director/Board Member	56	2023-03-07

Composition of the Board of Directors

Shareholders: BRAIN Biotech AG

Name	Equities	%	Valuation
Martin Putsch 31.5 %	6,881,961	31.5 %	21 M €
Pbg Zweite GmbH 15.1 %	3,298,972	15.1 %	10 M €
Daniel Hopp 5.6 %	1,223,459	5.6 %	4 M €
Universal-Investment-Gesellschaft mbH (Invt Mgmt) 2.988 %	652,894	2.988 %	2 M €
FPM Frankfurt Performance Management AG 1.753 %	383,000	1.753 %	1 M €

List of BRAIN BIOTECH AG shareholders

Company details: BRAIN Biotech AG

BRAIN Biotech AG

Darmstädter Strasse 34-36

64673, Zwingenberg

+49 62 51 9331 0

http://www.brain-biotech.de

Environmental Biotechnology

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi.($)
BRAIN BIOTECH AG	+0.37%	+15.38%	+12.03%	-59.94%	67.48M
AVANTIUM N.V.	+1.59%	+2.68%	-61.34%	-84.77%	186M
VYTRUS BIOTECH, S.A.	-1.56%	+12.50%	+353.24%	+270.59%	108M
AFYREN	+2.18%	+3.57%	+87.96%	-40.87%	90.96M
Average	+0.64%	+8.53%	+97.97%	+21.25%	113.16M
Weighted average by Cap.	+0.77%	+7.11%	+78.94%	+12.90%